We promote research excellence in endocrinology and related fields by ensuring the needs and interests of researchers are met. We foster innovation by making knowledge easily found and shared. And we are committed to ensuring the expertise and perspective of science is represented at research funding agencies and reflected in policies and national issues that impact researchers.
A recent clinical trial reveals encouraging news for a Cushing’s disease treatment. A poster from ENDO 2025 showed that osilodrostat provides sustained clinical benefits in Cushing’s patients who experienced positive outcomes by the end of the treatment period. Richard Auchus, MD, PhD, discusses how the data reinforces the drug’s use, which was well-tolerated for extended periods.
Carol A. Lange, PhD, past Editor-in-Chief of Endocrinology, and Stephen R. Hammes, MD, PhD, past Editor-in-Chief of Molecular Endocrinology share critical tips on how to get published.
Explore resources for pursuing endocrine-related research opportunities.
Join our endocrine community and become a member! Only members receive access to a variety of member benefits that will enhance your career. If your membership has lapsed, rejoin today so that you can continue to receive your membership benefits.
